Ahmad, Irfan
Chufal, Kundan Singh
Miller, Alexis Andrew
Bajpai, Ram
Umesh, Preetha
Sokhal, Balamrit Singh
Bhatia, Kratika
Pati, Shilpa
Gairola, Munish
Article History
Received: 25 May 2024
Accepted: 23 August 2024
First Online: 29 August 2024
Declarations
:
: This study’s protocol was submitted to and reviewed by the Institutional Review Board and Ethics Committee (IRB/IEC) of Rajiv Gandhi Cancer Institute & Research Centre, New Delhi, India (RGCIRC). After protocol review the IRB/IEC of RGCIRC approved the study and since all patients provided consent for DIBH assessment and treatment, the need for a separate consent for this study was waived (RES/SCM/62/2024/ 01). The IRB/IEC of RGCIRC is registered with Department of Health Research (EC/NEW/INST/2020/74).
: Not Applicable.
: The authors declare no competing interests.